PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
Clinical trial NCT05697198 · COMPLETED
Trial details
- NCT number
- NCT05697198
- Sponsor
- Labcorp Corporation of America Holdings, Inc
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-19
- Primary completion
- 2024-12-31
- Enrollment
- 1429
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.